NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered GHK-Cu from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply
+4 more ↓
73%
Finnrick rating
#136 of 140 GHK-Cu vendors
2 of 6 classifiable tests passed
natural 33% · customers 4.4★ (8)
methodology · Purity focus
Finnrick analysis · GHK-Cu

Tianjin Eleli's GHK-Cu evidence is dominated by quantity failures despite consistent 99.9% purity and identity passes. After an initial -17% fill pass, later vials missed by -38%, +89%, and -73%, pointing to fill volatility.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Eleli Technology Development

Source code, product-origin fields and a hidden mail target point beyond the Tianjin storefront to a second operator. The report traces the claimed address, young domain, offshore contact rails, dead Discord invites and unsupported FDA/warehouse claims.

21 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.87
76%
16
2
GHK-Cuselected
$0.07
73%
6
3
Tirzepatide
$0.38
63%
7
4
BPC-157
$0.75
53%
6
5
Cagrilintide
$2.16
52%
1
6
Tesamorelin
$1.81
47%
4
7
TB-500
$1.65
36%
3
8
GLOW
-
-
0
9
Ipamorelin
$1.24
-
0
10
Melanotan II
$0.45
-
0
11
NAD+
$0.01
-
0
12
PT-141
$0.56
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Feb 2026: 89%22 Feb 2026: 85%18 Mar 2026: 81%15 Jun 2026: 77%24 Jun 2026: 78%12 Aug 2026: 73%29 Sep 2026: current 73%89%77%73%Feb 26Sep 26
Showing GHK-Cu tests only
Tianjin Eleli Technology Development GHK-Cu test history
COA-backed lab tests

About Tianjin Eleli Technology Development test results from Finnrick

Tianjin Eleli Technology Development is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Eleli Technology Development peptides in this dataset are BPC-157 (6 tests), Cagrilintide (1 test) and GHK-Cu (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered GHK-Cu from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply